Abstract:Yanan Feng, 1, 2, &ast Yongsheng Hao, 3, &ast Yuanyuan Wang, 3 Weijian Song, 1, 4 Shanxin Zhang, 1 Dong Ni, 5 Fei Yan, 3 Litao Sun 1 1 Cancer Center, Department of Ultrasound Medicine, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, 310014, People's Republic of China; 2 Department of Abdominal Ultrasound, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, 266000, People's Republic of China; 3 Center for Cell and Gene Circuit Design, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, People's Republic of China; 4 Bengbu Medical College, Bengbu, 233030, People's Republic of China; 5 Medical Ultrasound Image Computing (MUSIC) Laboratory, Shenzhen University, Shenzhen, 518055, People's Republic of China &astThese authors contributed equally to this work Correspondence: Litao Sun; Fei Yan, Tel +86 13946037056, Email ; Purpose: Ultrasound molecular imaging (UMI) has proven promising to diagnose the onset and progression of diseases such as angiogenesis, inflammation, and thrombosis. However, microbubble-based acoustic probes are confined to intravascular targets due to their relatively large particle size, greatly reducing the application value of UMI, especially for extravascular targets. Extradomain B fibronectin (ED-B FN) is an important glycoprotein associated with tumor genesis and development and highly expressed in many types of tumors. Here, we developed a gas vesicles (GVs)-based nanoscale acoustic probe (ZD2-GVs) through conjugating ZD2 peptides which can specially target to ED-B FN to the biosynthetic GVs. Materials and Methods: ED-B FN expression was evaluated in normal liver and tumor tissues with immunofluorescence and Western blot. ZD2-GVs were prepared by conjugating ZD2 to the surface of GVs by amide reaction. The inverted microscope was used to analyze the targeted binding capacity of ZD2-GVs to MB49 cells (bladder cancer cell line). The contrast-enhanced imaging features of GVs, non-targeted control GVs (CTR-GVs), and targeted GVs (ZD2-GVs) were compared in three MB49 tumor mice. The penetration ability of ZD2-GVs in tumor tissues was assessed by fluorescence immunohistochemistry. The biosafety of GVs was evaluated by CCK8, blood biochemistry, and HE staining. Results: Strong ED-B FN expression was observed in tumor tissues while little expression in normal liver tissues. The resulting ZD2-GVs had only 267.73 ± 2.86 nm particle size and exhibited excellent binding capability to the MB49 tumor cells. The in vivo UMI experiments showed that ZD2-GVs produced stronger and longer retention in the BC tumors than that of the non-targeted CTR-GVs and GVs. Fluorescence immunohistochemistry confirmed that ZD2-GVs could penetrate the tumor vascular into the interstitial space of the tumors. Biosafety analysis revealed there was no significant cytotoxicity to these tested mice. Conclusion: Thus, ZD2-GVs can function as a potential UMI probe for the early diagnosis of bladder cancer. Graphical Keywords: ultrasound contrast agents, gas vesicles, ultrasound molecular imaging, tumor diagnosis Graphical In the past decades, the emergence of ultrasound molecular imaging (UMI) has attracted gradually increasing interest due to its capability to assess dynamic changes at the cellular and molecular levels. However, most commonly developed ultrasonic probes are based on the micron-sized (1–10 μm), gas-containing microbubbles that can only remain within the vascular lumen, which limits their application potential in extravascular diseased tissues or cells, such as tumors. 1–3 By contrast, nano-sized bubbles have the advantages over microbubbles, with can penetrate blood vessels and reach the extravascular tissue space, especially for tumors. Recently, targeted or non-targeted nanobubbles (NBs) consisting of various phospholipid or polymer shells have been developed for the ultrasound contrast agents. 4 At present, chemically synthesized nanoscale contrast agents have been reported to have good acoustic properties, most of them have particle sizes greater than 500 nm, limiting tumor penetration performance. 5–8 Recently, the nanoscale biosynthetic gas vesicles (GVs) with 200 nm particle size from Halobacterium NRC-1 (Halo) have been demonstrated excellent ultrasound contrast signals in murine livers and stronger tumor penetration capability for tumors -Abstract Truncated-

A Bioengineered Cathepsin B-sensitive Gas Vesicle Nanosystem That Responds With Increased Gray-level Intensity of Ultrasound Biomicroscopic Images

Intracellular Construction of Cathepsin B-Guided Gadolinium Nanoparticles for Enhanced T2 -Weighted MR Tumor Imaging.

Genetic Modulation of Biosynthetic Gas Vesicles for Ultrasound Imaging

Characterization and Comparison of Contrast Imaging Properties of Naturally Isolated and Heterologously Expressed Gas Vesicles

Ultrasound Molecular Imaging of Bladder Cancer via Extradomain B Fibronectin-Targeted Biosynthetic GVs

Characterisation of Gas Vesicles as Cavitation Nuclei for Ultrasound Therapy using Passive Acoustic Mapping

Protein Gas Vesicles of Bacillus megaterium as Enhancers of Ultrasound-Induced Transcriptional Regulation

Cathepsin B-Activated PET Tracer for In Vivo Tumor Imaging

Lysosome-Targeting Fluorogenic Probe For Cathepsin B Imaging In Living Cells

Cathespin B‐Initiated Cypate Nanoparticle Formation for Tumor Photoacoustic Imaging

Acoustic biosensors for ultrasound imaging of enzyme activity

In Vivo Visualization Of Gamma-Glutamyl Transpeptidase Activity With An Activatable Self-Immobilizing Near-Infrared Probe

Cathepsin B Turning Bioluminescence "On" for Tumor Imaging

Enzymatic Cleavage and Subsequent Facile Intramolecular Transcyclization for in Situ Fluorescence Detection of Γ-Glutamyltranspetidase Activities

Cell-Membrane-Localizing, Two-Photon Probe for Ratiometric Imaging of γ-Glutamyl Transpeptidase in Cancerous Cells and Tissues

Biosynthetic Gas Vesicles Combined with Focused Ultrasound for Blood–Brain Barrier Opening

Gas Vesicle-Blood Interactions Enhance Ultrasound Imaging Contrast

An Activatable Chemiluminescent Probe for Sensitive Detection of Γ-Glutamyl Transpeptidase Activity in Vivo

Advances in the application of gas vesicles in medical imaging and disease treatment

Preclinical Evaluation of an Activity-Based Probe for Intraoperative Imaging of Esophageal Cancer

Highly Sensitive Light-Up Near-Infrared Fluorescent Probe for Detection and Imaging of Β-Glucuronidase in Human Serum, Living Cells and Tumor-Bearing Mice